My ePortfolio Register   
 

Abstract | Full HTML Article | PDF ecancer 11 725 / https://doi.org/10.3332/ecancer.2017.725

Conference Report

Highlights from the 58th meeting of the American Society of Haematology, 1–6 December 2016, San Diego, USA

The recent 58th Annual American Society of Haematology (ASH) meeting held in San Diego shed light on the usual mixture of groundbreaking basic and translational science and the recent practice-changing clinical trials. Recurrent themes this year were the use of recent next-generation sequencing (NGS) techniques to perfect prognostic stratification and disease monitoring. Newer prospects on the role of metabolism in normal and malignant haemopoiesis and mature data on long-awaited trials on immunotherapy and CAR-T cells in lymphoid neoplasms were also discussed.

Keywords: leukaemia, lymphoma, minimal residual disease, sequencing, clinical trial, CAR T cell

Categories:

Haematology oncology

Loading Article Metrics ... Please wait

Related videos

Related articles

Special Issue: Acute myeloid leukaemia at an early age: Reviewing the interaction between pesticide exposure and KMT2A-rerrangments

Abstract | Full Article | PDF Published: 30 Nov 2017 / https://doi.org/10.3332/ecancer.2017.782

Case Report: Use of PEG-asparaginase in monomorphic epitheliotropic intestinal T-cell lymphoma, a disease with diagnostic and therapeutic challenges

Abstract | Full Article | PDF Published: 27 Sep 2017 / https://doi.org/10.3332/ecancer.2017.771

Conference Report: Highlights from the WIN 2017 Symposium, 26–27 June 2017, Paris, France: ‘Expediting Global Innovation in Precision Cancer Medicine’

Abstract | Full Article | PDF Published: 27 Sep 2017 / https://doi.org/10.3332/ecancer.2017.770

Case Report: Deterioration of duodenal lymphangiectasia after radiotherapy for gastric MALT lymphoma

Abstract | Full Article | PDF Published: 11 Jul 2017 / https://doi.org/10.3332/ecancer.2017.752

Clinical Study: Study of clinical, haematological and cytogenetic profile of patients with acute erythroid leukaemia

Abstract | Full Article | PDF Published: 10 Jan 2017 / https://doi.org/10.3332/ecancer.2017.712



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence